Hematology
Andrew Lane, M.D., PH.D.
Director, Blastic Plasmacytoid Dendritic Cell Neoplasm Center; Associate Professor of Medicine, Harvard Medical School
Boston, MA
Dr. Andrew Lane is a physician at Dana-Farber Cancer Institute specializing in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Leukemias, Stem cell transplantation, serving as Director, Blastic Plasmacytoid Dendritic Cell Neoplasm Center; Associate Professor of Medicine, Harvard Medical School.
20+
Years in Practice
Credentials
Board Certifications
- Hematology, 2012
- Internal Medicine, 2009
- Medical Oncology, 2012
Education & Training
- Washington University (MD)
- Brigham and Women's Hospital, Internal Medicine (Residency)
- Dana-Farber/Partners CancerCare, Hematology/Oncology (Fellowship)
Clinical Focus
Subspecialties
Hematology & Oncology
Conditions & Treatments
LeukemiaLymphomaMultiple MyelomaHematologic Malignancies
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Experience
20+ years in practice